Liabilities and Equity of CLOVER HEALTH INVESTMENTS, CORP. /DE from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
CLOVER HEALTH INVESTMENTS, CORP. /DE quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • CLOVER HEALTH INVESTMENTS, CORP. /DE Liabilities and Equity for the quarter ending 31 Dec 2025 was $541,011,000, a 6.8% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $541,011,000 -$39,731,000 -6.8% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $559,659,000 -$93,354,000 -14% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $574,987,000 -$99,223,000 -15% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $583,717,000 -$88,053,000 -13% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $580,742,000 +$10,071,000 +1.8% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $653,013,000 -$406,784,000 -38% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $674,210,000 -$583,787,000 -46% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $671,770,000 -$781,819,000 -54% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $570,671,000 -$237,949,000 -29% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $1,059,797,000 -$497,882,000 -32% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $1,257,997,000 -$805,209,000 -39% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $1,453,589,000 -$1,226,305,000 -46% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $808,620,000 -$142,184,000 -15% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $1,557,679,000 +$605,201,000 +64% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $2,063,206,000 +$847,309,000 +70% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $2,679,894,000 +$1,812,952,000 +209% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $950,804,000 +$683,552,000 +256% 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 $952,478,000 +$123,789,266 +15% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $1,215,897,000 +$386,651,753 +47% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $866,942,000 +$216,057,000 +33% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $267,252,000 +$267,151,654 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $828,688,734 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $829,245,247 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $650,885,000 31 Mar 2020 10-Q 04 Jun 2020 2020 Q1
Q4 2019 $100,346* 31 Dec 2019 10-K 31 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.